Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension
International Journal of Molecular Sciences · 16.02.2023 · 24 (4) · 3979
DOI: 10.3390/ijms24043979 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.02.2023. Verfasst von Naoyuki Otani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Dokkyo Medical University Nikkyo Medical Center, Nikko 321-1298, Japan. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Pulmonary Embolism, Angioplasty, Balloon. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition in which an organic thrombus remains in the pulmonary artery (PA) even after receiving anticoagulation therapy for more than 3 months and is complicated by pulmonary hypertension (PH), leading to right-sided heart failure and death. CTEPH is a progressive pulmonary vascular disease with a poor prognosis if left untreated. The standard treatment for CTEPH is pulmonary endarterectomy (PEA), which is usually performed only in specialized centers. In recent years, balloon pulmonary angioplasty (BPA) and drug therapy for CTEPH have also shown good results. This review discusses the complex pathogenesis of CTEPH and presents the standard of care, PEA, as well as a new device called BPA, which is showing remarkable progress in efficacy and safety. Additionally, several drugs are now demonstrating established evidence of efficacy in treating CTEPH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Dokkyo Medical University Nikkyo Medical Center, Nikko 321-1298, Japan.
- Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu 321-0293, Japan.
ORCID-Profile: Shigeru Toyoda, Takanori Yasu
Zitieren
APA
Otani, N., Watanabe, R., Tomoe, T., Toyoda, S., Yasu, T., & Nakamoto, T. (2023). Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension. International Journal of Molecular Sciences, 24(4), 3979. https://doi.org/10.3390/ijms24043979
Vancouver
Otani N, Watanabe R, Tomoe T, Toyoda S, Yasu T, Nakamoto T. Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension. International Journal of Molecular Sciences. 2023;24(4):3979. doi:10.3390/ijms24043979
BibTeX
@article{Otani2023,
author = {Otani, Naoyuki and Watanabe, Ryo and Tomoe, Takashi and Toyoda, Shigeru and Yasu, Takanori and Nakamoto, Takaaki},
title = {Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3979},
doi = {10.3390/ijms24043979}
}
EUVIMED